Together, our study showed that circSEMA4B is a critical negative regulator of PI3K/AKT signaling in BC tumorigenesis through at least two ways: encoding a novel protein SEMA4B-211aa and regulating miR-330-3p/PDCD4 axis (Fig. 8g). This evidence concerns the gene AKT1 and breast cancer.